Medicare受益人全关节置换术的费用与结局与产业支付无实质性关联
研究匹配2013至2015年20%医疗保险样本中130,872例全髋关节置换术(THA)和230,856例全膝关节置换术(TKA),分析产业支付与手术费用及结局的关系。多数关节置换外科医生接受产业支付,但少数医生获得大部分支付。经多变量调整后,产业支付对关节置换费用和结局无实质性影响。
要点
- 96.7%的THA医生和97.4%的TKA医生接受产业支付,但少数医生获得大部分支付。
- 产业支付每增加1000美元,THA总费用增加0.50美元(占总费用0.003%),手术室费用增加0.20美元(占总费用0.003%)。
- 产业支付与TKA费用及THA或TKA术后30天死亡率无关,与THA再入院几率增加<0.1%独立相关。
核心结论
- 尽管多数关节置换外科医生接受产业支付,但少数医生获得大部分支付,总体上关节置换费用和结局未受产业关系实质性影响。
研究设计与样本
- 匹配Open Payments数据与2013至2015年20%医疗保险样本中由7,539名医生施行的130,872例初次择期THA及由8,977名医生施行的230,856例初次择期TKA。
- 收集患者、医院和医生因素,记录总费用、手术室费用、住院时间、死亡率和再入院,采用多变量线性和逻辑回归模型分析风险调整后关系。
主要发现
- 96.7%的THA医生和97.4%的TKA医生接受产业支付。
- 产业支付每增加1000美元,THA总费用增加0.50美元(占总费用0.003%),THA手术室费用增加0.20美元(占总费用0.003%)。
- 产业支付与TKA费用无关,与THA或TKA术后30天死亡率无关。
- 产业支付每增加1000美元,THA住院时间独立减少0.0045天,TKA住院时间独立减少0.0035天,THA再入院几率增加<0.1%。
- 接受产业支付最高5%的医生,THA总费用中位数高300美元(p < 0.001),TKA总费用中位数低150美元(p < 0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior studies have demonstrated that industry payments affect physician prescribing patterns, but their effect on orthopaedic surgical costs is unknown. This study examines the relationship between industry payments and the total costs of primary total joint arthroplasty, as well as operating room cost, length of stay, 30-day mortality, and 30-day readmission. METHODS: Open Payments data were matched across a 20% sample of Medicare-insured patients undergoing primary elective total hip arthroplasty (THA) (n = 130,872) performed by 7,539 surgeons or primary elective total knee arthroplasty (TKA) (n = 230,856) performed by 8,977 surgeons from 2013 to 2015. Patient, hospital, and surgeon-specific factors were gathered. Total and operating room costs, length of stay, mortality, and readmissions were recorded. Multivariable linear and logistic regression models were used to identify the risk-adjusted relationships between industry payments and the primary and secondary outcomes. RESULTS: In this study, 96.7% of THA surgeons and 97.4% of TKA surgeons received industry payments. After multivariable risk adjustment, for each $1,000 increase in industry payments, the total costs of THA increased by $0.50 (0.003% of total costs) and the operating room costs of THA increased by $0.20 (0.003% of total costs). Industry payments were not associated with TKA cost. Industry payments were not associated with 30-day mortality after either THA or TKA. Higher industry payments were independently associated with a marginal decrease in the length of stay for patients undergoing THA (0.0045 days per $1,000) or TKA (0.0035 days per $1,000) and a <0.1% increase in the odds of 30-day readmission after THA for every $1,000 in industry payments. The median total THA costs were $300 higher (p < 0.001), whereas the median TKA costs were $150 lower (p < 0.001), for surgeons receiving the highest 5% of industry payments. These surgical procedures were more often performed in large urban areas, in hospitals with a higher number of beds, with a higher wage index, and by more experienced surgeons and were associated with a 0.4 to 1-day shorter length of stay (p < 0.001). CONCLUSIONS: Although most arthroplasty surgeons received industry payments, a minority of surgeons received the majority of payments. Overall, arthroplasty costs and outcomes were not meaningfully impacted by industry relationships. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Wadhwa H, Leung C, Sklar M, et al. Costs and Outcomes of Total Joint Arthroplasty in Medicare Beneficiaries Are Not Meaningfully Associated with Industry Payments. J Bone Joint Surg Am. 2023. PMID: 37992189. doi:10.2106/JBJS.23.00768
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。